$145m cash, book value $7.71, PE 3.36, foreward PE 2.01, sales 10X enterprise value, quarterly rev. growth 23%, net profit 1/2 of Enterprise value, qtrly, earnings growth 15.7%, and everything moves on wheels. Please find me a more undervalued company. I will buy. I'm waiting.
People, it is too obvious that this stock is worth a LOT more than the current price. This is one of those rare small cap Chinese companies that is PROFITABLE and its business has a lot to grow. Read anywhere, the number of cars is going to keep increasing for the next 10-20 years and ZX will benefit from this.
Just be patient and wait. This stock will go up, it's just a matter of time. Stay positive and hold on to your shares.
The problem is that you have an out off control CEO that wants to do as he pleases with complete disregard for the stockholders. If he would not have put the request for restructure the stock would be well over $4. The other problem is the board has no balls to say "Just say NO" to the proposal or respond in a timely manner. This stock will go nowhere until they make a decision.
The "special committee" which was supposed to evaluate this buyout proposal is as crooked as the CEO with his bogus buyout offer and today's announcement proves it. They first took about five months to hire a firm as consultants to look into this matter and then stated that this may go on without a time frame and that there is no committeemen on the part of the buyers and that they could withdraw the offer anytime and that the company is investigating this at shareholders' expense without the CEO and associates be responsible for it and that there is no assurance that anything will happen. This is clearly an intentional and planned statement to generate more uncertainty and encourage more selling while the CEO and associates are accumulating cheap shares at artificialy manipulated prices. In the end the offer will be withdrawn and a cash offer will be made for the remaining shares. The cash offer has to be above $3.50 in order to prevent other complications.